Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v2.4.0.8
Consolidated Condensed Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
 3 Months Ended
Mar. 29, 2014
Mar. 30, 2013
Cash and cash equivalents, beginning of period $ 5,674 $ 8,478
Cash flows provided by (used for) operating activities:    
Net income 1,930 2,045
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 1,720 1,682
Share-based compensation 283 295
Restructuring and asset impairment charges 137 0
Excess tax benefit from share-based payment arrangements (7) (1)
Amortization of intangibles 287 382
(Gains) losses on equity investments, net (48) 26
Deferred taxes (25) (56)
Changes in assets and liabilities:    
Accounts receivable 78 293
Inventories 405 372
Accounts payable (95) (17)
Accrued compensation and benefits (1,229) (1,370)
Income taxes payable and receivable 200 257
Other assets and liabilities (135) 377
Total adjustments 1,571 2,240
Net cash provided by operating activities 3,501 4,285
Cash flows provided by (used for) investing activities:    
Additions to property, plant and equipment (2,689) (2,174)
Acquisitions, net of cash acquired (108) (98)
Purchases of available-for-sale investments (2,509) (3,475)
Sales of available-for-sale investments 174 304
Maturities of available-for-sale investments 2,913 1,711
Purchases of trading assets (3,225) (5,191)
Maturities and sales of trading assets 2,693 3,558
Collection of loans receivable 8 8
Investments in non-marketable equity investments (144) (35)
Return of equity method investments 0 13
Proceeds from divestitures 150 0
Other investing (12) 95
Net cash used for investing activities (2,749) (5,317)
Cash flows provided by (used for) financing activities:    
Increase (decrease) in short-term debt, net (245) (224)
Excess tax benefit from share-based payment arrangements 7 1
Proceeds from sales of shares through employee equity incentive plans 479 465
Repurchase of common stock (572) (559)
Payment of dividends to stockholders (1,119) (1,114)
Other financing (200) (307)
Net cash used for financing activities (1,650) (1,738)
Effect of exchange rate fluctuations on cash and cash equivalents 1 (10)
Net increase (decrease) in cash and cash equivalents (897) (2,780)
Cash and cash equivalents, end of period 4,777 5,698
Cash paid during the period for:    
Income taxes, net of refunds 571 200
Licensed Technology and Patents [Member]
    
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of intangibles 68 66
Cash flows provided by (used for) investing activities:    
Purchases of licensed technology and patents $ 0 $ (33)